Predilife Revenue and Competitors
Estimated Revenue & Valuation
- Predilife's estimated annual revenue is currently $9.5M per year.
- Predilife's estimated revenue per employee is $251,000
Employee Data
- Predilife has 38 Employees.
- Predilife grew their employee count by -5% last year.
Predilife's People
Name | Title | Email/Phone |
---|
Predilife Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.1M | 49 | -18% | $10M | N/A |
#2 | $30.4M | 121 | 29% | N/A | N/A |
#3 | $139.8M | 913 | -3% | $200K | N/A |
#4 | $84.1M | 0 | N/A | $1.2M | N/A |
#5 | $43.4M | 173 | 30% | N/A | N/A |
#6 | $64.5M | 257 | 12% | N/A | N/A |
#7 | $64.3M | 205 | 26% | $129.6M | N/A |
#8 | $19.6M | 78 | -7% | N/A | N/A |
#9 | $65.8M | 262 | 7% | N/A | N/A |
#10 | $73.7M | 235 | 20% | $115.5M | N/A |
What Is Predilife?
Predilife is an innovative company specializing in statistics and data mining applied to predictive and preventive medicine. Predilife designed Mammorisk solution: - An expert software for calculating the breast cancer risk of your patient; streamlined and easy to use in your daily workflow - Results in graphic form that can easily be shared with the patient and prescribers. - Automatic creation of a personalized multi year, individualized screening plan - Adjustment of the frequency and imaging modalities (US, MRI..) of your patient's screening plan, based on her own breast cancer risk, from official recommendations. - Performs automatically a qualitative assessment of breast density, simulates the visual evaluation by the radiologist MammoRisk, designed in collaboration with the center Gustave Roussy (Paris, France), was the subject of a patent application regarding the methodology "Nearest Neighbours" applied to the prediction of diseases. Statlife, The sooner, the better
keywords:N/AN/A
Total Funding
38
Number of Employees
$9.5M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Predilife News
Villejuif, France, le 7 avril 2022, 7h - PREDILIFE (Euronext Growth : ALPRE FR0010169920), spécialiste de solutions innovantes de prédiction...
Predilife : NUOMA, LA MUTUELLE DE LA " HIGH TECH ", PREMIERE MUTUELLE A REMBOURSER LES BILANS DE PREDICTION DU CANCER DU SEIN. Lien copié. 07/04...